# Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects

> **NCT01705938** · PHASE1 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Exposure

## Interventions

- **DRUG:** SP-333

## Key facts

- **NCT ID:** NCT01705938
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01705938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01705938, "Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT01705938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*